Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4016561)

Published in Trials on October 01, 2013

Authors

Suk Jae Kim1, Gyeong Joon Moon, Won Hyuk Chang, Yun-Hee Kim, Oh Young Bang, STARTING-2 (STem cell Application Researches and Trials In NeuroloGy-2) collaborators

Author Affiliations

1: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, 135-710, Gangnam-gu, Seoul, South Korea. nmboy@unitel.co.kr.

Associated clinical trials:

The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study (STARTING-2) | NCT01716481

Articles cited by this

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35

Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10

Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol (2005) 5.31

Motor evaluation in vascular hemiplegia. Eur Neurol (1980) 3.19

A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol (2008) 3.00

Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res (2007) 2.98

Treatment of neural injury with marrow stromal cells. Lancet Neurol (2002) 2.89

Subventricular zone-derived neuroblasts migrate and differentiate into mature neurons in the post-stroke adult striatum. J Neurosci (2006) 2.79

Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun (2007) 2.67

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther (2007) 2.55

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells (2010) 2.50

Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke (2004) 2.49

Treatment effects for which shift or binary analyses are advantageous in acute stroke trials. Neurology (2008) 2.48

Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab (2004) 2.41

Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther (2004) 2.35

Cell transplantation therapy for stroke. Stroke (2007) 2.30

Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol (2008) 2.16

Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab (2006) 2.10

Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke (2008) 2.08

FDA regulation of stem-cell-based therapies. N Engl J Med (2006) 2.01

SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol (2004) 1.94

Mobility after stroke: reliability of measures of impairment and disability. Int Disabil Stud (1990) 1.94

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain (2011) 1.73

Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther (1986) 1.71

Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol (2011) 1.64

Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells (2007) 1.62

Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol (2012) 1.60

Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke (2011) 1.58

Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke (2004) 1.58

Validation of the Box and Block Test as a measure of dexterity of elderly people: reliability, validity, and norms studies. Arch Phys Med Rehabil (1994) 1.51

Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke (2012) 1.43

Stroke-induced neurogenesis in aged brain. Stroke (2005) 1.38

The Met allele of the BDNF Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke (2007) 1.34

Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33

Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol (2002) 1.33

Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis (2005) 1.24

Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab (2010) 1.19

Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant (2012) 1.19

Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke (2006) 1.15

Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. Stroke (2010) 1.12

Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke (2012) 1.11

Regulation of stroke-induced neurogenesis in adult brain--recent scientific progress. Cereb Cortex (2006) 1.10

Considerations in the design of clinical trials of neuroprotective therapy in acute stroke. Stroke (1996) 1.06

Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra (2011) 1.05

Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant (2008) 1.02

Recovery and rehabilitation in stroke: stem cells. Stroke (2004) 1.01

Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes. Brain Res Rev (2009) 0.99

De novo neurogenesis and acute stroke: are exogenous stem cells really necessary? Neurosurgery (2004) 0.97

Efficiency perspectives on adaptive designs in stroke clinical trials. Stroke (2011) 0.94

Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology (2012) 0.92

Restoring neuronal function after stroke by cell replacement: anatomic and functional considerations. Stroke (2011) 0.91

Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev (2010) 0.91

Upper extremity function in hemiplegia. A cross-validation study of two assessment methods. Scand J Rehabil Med (1986) 0.91

Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-years. Stroke (2011) 0.89

Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem (1998) 0.88

Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS One (2012) 0.88

Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage. Neurosurgery (2008) 0.88

Preconditioning improves function and recovery of single muscle fibers during severe hypoxia and reoxygenation. Am J Physiol Cell Physiol (2001) 0.84

Time course and outcome of recovery from stroke: relevance to stem cell treatment. Exp Neurol (2006) 0.84

Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory. J Clin Neurol (2005) 0.81

Clinical trials of stroke therapy: which cells, which patients? Stroke (2008) 0.78

Autologous cell therapies: the importance of regulatory oversight. Regen Med (2012) 0.76

Articles by these authors

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells (2010) 2.50

Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke (2013) 2.19

Coagulopathy and embolic signal in cancer patients with ischemic stroke. Ann Neurol (2010) 2.11

Newly suggested surgical method of decompressive craniectomy for patients with middle cerebral artery infarction. Neurologist (2011) 2.10

Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol (2006) 2.00

Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke (2006) 1.76

Longitudinal changes of resting-state functional connectivity during motor recovery after stroke. Stroke (2011) 1.75

Virtual reality-induced cortical reorganization and associated locomotor recovery in chronic stroke: an experimenter-blind randomized study. Stroke (2005) 1.68

Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients. Eur Neurol (2014) 1.54

Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke (2010) 1.53

Vasopressin effectively suppresses male fertility. PLoS One (2013) 1.52

Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by (99m)Tc-HMPAO labeling. Nucl Med Biol (2011) 1.51

Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia (2009) 1.47

Primary motor cortex activation by transcranial direct current stimulation in the human brain. Neurosci Lett (2008) 1.46

Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment. Neuroimage (2007) 1.42

Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40

Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory. Neuroreport (2008) 1.39

NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation. Mol Cell Biol (2004) 1.37

Analysis of antioxidant enzyme activity during germination of alfalfa under salt and drought stresses. Plant Physiol Biochem (2009) 1.32

Motor outcome according to the integrity of the corticospinal tract determined by diffusion tensor tractography in the early stage of corona radiata infarct. Neurosci Lett (2007) 1.32

Enhancing the working memory of stroke patients using tDCS. Am J Phys Med Rehabil (2009) 1.22

MR mismatch profiles in patients with intracranial atherosclerotic stroke: a comprehensive approach comparing stroke subtypes. J Cereb Blood Flow Metab (2009) 1.20

Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Stroke (2009) 1.20

Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis. Blood (2008) 1.15

Cortical reorganization induced by virtual reality therapy in a child with hemiparetic cerebral palsy. Dev Med Child Neurol (2005) 1.14

Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes (2003) 1.14

Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem (2008) 1.12

Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center For Stroke. J Stroke (2013) 1.11

Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging (2003) 1.08

Induction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 mice. Exp Mol Med (2010) 1.08

Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke (2010) 1.08

Cortical reorganization induced by task-oriented training in chronic hemiplegic stroke patients. Neuroreport (2003) 1.04

Long-term effects of rTMS on motor recovery in patients after subacute stroke. J Rehabil Med (2010) 1.04

Different brain activation patterns to pain and pain-related unpleasantness during the menstrual cycle. Anesthesiology (2006) 1.02

Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant (2008) 1.02

Effects of hippotherapy on gait parameters in children with bilateral spastic cerebral palsy. Arch Phys Med Rehabil (2011) 1.02

Diffusion anisotrophy in the early stages of stroke can predict motor outcome. Restor Neurol Neurosci (2005) 1.00

A novel magnetic resonance imaging approach to collateral flow imaging in ischemic stroke. Ann Neurol (2014) 0.97

Effects of robot-assisted gait training on cardiopulmonary fitness in subacute stroke patients: a randomized controlled study. Neurorehabil Neural Repair (2011) 0.97

Subcortical white matter infarcts: comparison of superficial perforating artery and internal border-zone infarcts using diffusion-weighted magnetic resonance imaging. Stroke (2003) 0.97

Quantitative analysis of nociceptin in blood of patients with acute and chronic pain. Neuroreport (2002) 0.97

Comparing quantitative tractography metrics of motor and sensory pathways in children with periventricular leukomalacia and different levels of gross motor function. Neuroradiology (2011) 0.96

Enhanced tolerance to methyl viologen-induced oxidative stress and high temperature in transgenic potato plants overexpressing the CuZnSOD, APX and NDPK2 genes. Physiol Plant (2010) 0.96

Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins. Cell Signal (2010) 0.95

Motor recovery mechanism of diffuse axonal injury: a combined study of transcranial magnetic stimulation and functional MRI. Restor Neurol Neurosci (2005) 0.95

Sweetpotato late embryogenesis abundant 14 (IbLEA14) gene influences lignification and increases osmotic- and salt stress-tolerance of transgenic calli. Planta (2010) 0.95

Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism. Neurology (2004) 0.94

Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol (2007) 0.94

Luteolin inhibits the nuclear factor-kappa B transcriptional activity in Rat-1 fibroblasts. Biochem Pharmacol (2003) 0.93

Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Oncogene (2002) 0.93

Short-term effects of combined serial casting and botulinum toxin injection for spastic equinus in ambulatory children with cerebral palsy. Yonsei Med J (2010) 0.93

Clues to occult cancer in patients with ischemic stroke. PLoS One (2012) 0.93

Downregulation of the lycopene ε-cyclase gene increases carotenoid synthesis via the β-branch-specific pathway and enhances salt-stress tolerance in sweetpotato transgenic calli. Physiol Plant (2012) 0.93

Variations in cortical thickness with dementia severity in Alzheimer's disease. Neurosci Lett (2008) 0.93

High frequency rTMS modulation of the sensorimotor networks: behavioral changes and fMRI correlates. Neuroimage (2007) 0.93

Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol (2005) 0.92

RGS2 promotes formation of neurites by stimulating microtubule polymerization. Cell Signal (2006) 0.92

Improvement of visual scanning after DC brain polarization of parietal cortex in stroke patients with spatial neglect. Neurosci Lett (2008) 0.92

Neural correlates of the antinociceptive effects of repetitive transcranial magnetic stimulation on central pain after stroke. Neurorehabil Neural Repair (2011) 0.92

Progressive Multifocal Leukoencephalopathy in AIDS: Proton MR Spectroscopy Patterns of Asynchronous Lesions Confirmed by Serial Diffusion-Weighted Imaging and Apparent Diffusion Coefficient Mapping. J Clin Neurol (2007) 0.92

Hippotherapy in adult patients with chronic brain disorders: a pilot study. Ann Rehabil Med (2012) 0.91

Evaluation of local electric fields generated by transcranial direct current stimulation with an extracephalic reference electrode based on realistic 3D body modeling. Phys Med Biol (2012) 0.91

Recovery of corticospinal tract with diffuse axonal injury: a diffusion tensor image study. NeuroRehabilitation (2007) 0.91

Long-term effects of transcranial direct current stimulation combined with computer-assisted cognitive training in healthy older adults. Neuroreport (2014) 0.90

Cortical activation changes associated with motor recovery in patients with precentral knob infarct. Neuroreport (2004) 0.90

Effects of dual transcranial direct current stimulation on post-stroke unilateral visuospatial neglect. Neurosci Lett (2013) 0.89

A myristoylated pseudosubstrate peptide of PKC-zeta induces degranulation in HMC-1 cells independently of PKC-zeta activity. Life Sci (2008) 0.89

Early experiences of elective stenting for symptomatic stenosis of the M1 segment of the middle cerebral artery: reports of three cases and review of the literature. J Clin Neurosci (2003) 0.89

rTMS with motor training modulates cortico-basal ganglia-thalamocortical circuits in stroke patients. Restor Neurol Neurosci (2012) 0.89

Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma. Cancer Lett (2012) 0.88

Overexpression of 2-cysteine peroxiredoxin enhances tolerance to methyl viologen-mediated oxidative stress and high temperature in potato plants. Plant Physiol Biochem (2011) 0.88

Perfusion-weighted MRI as a predictor of clinical outcomes following medullary infarctions. Cerebrovasc Dis (2010) 0.88

Apoptosis of human islet cells by cytokines. Immune Netw (2012) 0.88

Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS One (2012) 0.88

Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord (2006) 0.87

Demonstration of recovery of a severely damaged corticospinal tract: a diffusion tensor tractography and transcranial magnetic stimulation follow-up study. J Comput Assist Tomogr (2008) 0.87

The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats. Clin Chim Acta (2008) 0.87

Dissociable modulating effect of repetitive transcranial magnetic stimulation on sensory and pain perception. Neuroreport (2006) 0.86

Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol. Atherosclerosis (2012) 0.86

Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. BMB Rep (2009) 0.86

Cortical reorganization associated with motor recovery in hemiparetic stroke patients. Neuroreport (2003) 0.86

Association of serum bilirubin with ischemic stroke outcomes. J Stroke Cerebrovasc Dis (2008) 0.86

Topographic location of acute pontine infarction is associated with the development of progressive motor deficits. Stroke (2012) 0.86

Effect of hippotherapy on gross motor function in children with cerebral palsy: a randomized controlled trial. J Altern Complement Med (2014) 0.86

Stable internal reference genes for the normalization of real-time PCR in different sweetpotato cultivars subjected to abiotic stress conditions. PLoS One (2012) 0.85

Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice. BMC Neurosci (2011) 0.85

Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis (2009) 0.85

Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Clin Ther (2011) 0.85

DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. Nat Commun (2012) 0.85